Direxion Daily S&P Biotech Bull 3x Shares Rating $61.54 +0.84 (+1.38%) Closing price 07/3/2025 05:00 PM EasternExtended Trading$61.62 +0.09 (+0.14%) As of 07/3/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.74Holdings in LABU have an aggregate rating of Moderate Buy based on 688 analyst ratings issued in the past year covering 44 companies (47.1% of the portfolio).LABU Aggregate Price Target$61.54High Prediction$61.54Average Prediction$61.54Low Prediction$61.54Holdings in LABU have an aggregate price target of $61.54 and a range of $61.54 to $61.54 covering 44 companies (47.1% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.25%INSMInsmed$98.50+0.3%4.1598 of 5 stars3.00$106.80 8.4%17Positive News2.07%ALNYAlnylam Pharmaceuticals$331.94+0.7%4.3112 of 5 stars2.79$340.00 2.4%24Positive NewsAnalyst Upgrade1.93%NTRANatera$161.500.0%2.1624 of 5 stars3.00$184.63 14.3%15Positive NewsInsider Trade1.91%BPMCBlueprint Medicines$128.27+0.1%1.5724 of 5 stars2.27$128.06 -0.2%221.88%NBIXNeurocrine Biosciences$128.04-1.1%4.9188 of 5 stars2.86$162.00 26.5%22Positive News1.86%EXASExact Sciences$52.82-1.9%4.9415 of 5 stars2.95$70.40 33.3%22Analyst Revision1.64%INCYIncyte$68.46+0.4%4.3469 of 5 stars2.22$74.53 8.9%181.54%UTHRUnited Therapeutics$294.57-0.2%4.9954 of 5 stars2.69$386.15 31.1%13Positive News1.54%GILDGilead Sciences$111.28-0.2%4.8436 of 5 stars2.78$110.55 -0.7%27Positive NewsInsider Trade1.50%AMGNAmgen$298.25+0.5%4.5265 of 5 stars2.35$307.82 3.2%231.47%BIIBBiogen$132.63-0.4%4.9346 of 5 stars2.38$188.48 42.1%321.44%VRTXVertex Pharmaceuticals$454.64-0.5%4.7253 of 5 stars2.54$511.62 12.5%28Positive News1.42%ABBVAbbVie$189.50-0.7%4.908 of 5 stars2.81$211.29 11.5%27Trending NewsAnalyst Revision1.40%EXELExelixis$45.91+3.6%4.7485 of 5 stars2.52$43.56 -5.1%21Trending NewsAnalyst RevisionHigh Trading Volume1.28%MDGLMadrigal Pharmaceuticals$298.49-0.6%4.096 of 5 stars2.89$420.63 40.9%91.27%BBIOBridgeBio Pharma$43.71+2.0%4.7029 of 5 stars2.93$58.85 34.6%14News CoverageInsider TradeAnalyst Revision1.20%REGNRegeneron Pharmaceuticals$545.00-0.5%4.946 of 5 stars2.80$813.57 49.3%251.20%MRNAModerna$30.47+0.6%4.3808 of 5 stars2.04$46.61 53.0%23Options VolumeGap Up1.08%BMRNBioMarin Pharmaceutical$57.25+0.1%4.9468 of 5 stars2.75$93.61 63.5%24Analyst Forecast0.99%IONSIonis Pharmaceuticals$42.98-1.4%4.6679 of 5 stars2.78$58.25 35.5%18News CoverageAnalyst Upgrade0.98%TGTXTG Therapeutics$37.20+2.5%3.2899 of 5 stars2.80$40.80 9.7%50.97%RVMDRevolution Medicines$37.00-0.5%4.5904 of 5 stars3.00$67.58 82.7%12Analyst Revision0.97%CRSPCRISPR Therapeutics$52.16+0.9%3.0225 of 5 stars2.53$71.75 37.6%170.88%HALOHalozyme Therapeutics$54.05+0.4%4.8528 of 5 stars2.17$61.90 14.5%120.85%ROIVRoivant Sciences$10.85-1.1%1.5558 of 5 stars3.00$17.50 61.4%40.78%SWTXSpringWorks Therapeutics$46.991.3923 of 5 stars2.13$52.57 11.9%80.72%VKTXViking Therapeutics$28.16+1.6%4.366 of 5 stars3.00$87.15 209.5%14Trending NewsInsider TradeGap Up0.72%CYTKCytokinetics$33.90-1.3%3.9498 of 5 stars2.93$70.92 109.2%150.71%SMMTSummit Therapeutics$24.35+7.6%2.5296 of 5 stars2.79$34.67 42.4%14Trending NewsAnalyst ForecastOptions VolumeHigh Trading Volume0.68%ACADACADIA Pharmaceuticals$20.95-1.4%4.6299 of 5 stars2.71$27.88 33.1%170.66%ALKSAlkermes$28.75-0.9%4.9369 of 5 stars2.83$40.00 39.1%12Positive NewsAnalyst Revision0.65%PCVXVaxcyte$33.24-0.1%1.8029 of 5 stars3.10$136.50 310.7%10News Coverage0.64%RNAAvidity Biosciences$29.13-0.8%2.1866 of 5 stars3.06$65.59 125.2%170.60%AKROAkero Therapeutics$52.01+0.3%3.4701 of 5 stars3.00$82.50 58.6%6Insider Trade0.59%ADMAADMA Biologics$18.30+0.9%4.1158 of 5 stars3.33$27.67 51.2%30.58%NUVLNuvalent$80.37-0.2%3.7251 of 5 stars3.17$119.60 48.8%12Insider Trade0.57%SRRKScholar Rock$35.35-0.6%3.3574 of 5 stars3.14$42.67 20.7%70.56%SLNOSoleno Therapeutics$86.64+0.5%4.3831 of 5 stars3.09$107.10 23.6%11Insider Trade0.55%ACLXArcellx$67.30+1.4%2.9687 of 5 stars3.07$111.23 65.3%150.54%RYTMRhythm Pharmaceuticals$65.78-1.7%3.8182 of 5 stars3.00$77.31 17.5%13News Coverage0.52%TWSTTwist Bioscience$38.11+1.1%4.4827 of 5 stars2.70$50.40 32.2%10Positive News0.50%RAREUltragenyx Pharmaceutical$39.19-0.7%4.067 of 5 stars2.93$87.00 122.0%140.48%KRYSKrystal Biotech$143.01+1.2%4.5922 of 5 stars3.00$211.13 47.6%9News CoverageAnalyst Revision0.48%AGIOAgios Pharmaceuticals$36.06+2.0%4.1241 of 5 stars2.71$58.60 62.5%7Insider Trade This page (NYSEARCA:LABU) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts